KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Shares Outstanding (Weighted Average) (2016 - 2025)

Boston Scientific's Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 0.6% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, up 0.6%, while the annual FY2025 figure was $1.5 billion, 0.6% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $1.5 billion at Boston Scientific, roughly flat from $1.5 billion in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $1.5 billion in Q3 2025 and bottomed at $1.4 billion in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $1.4 billion (2023), against an average of $1.4 billion.
  • The largest annual shift saw Shares Outstanding (Weighted Average) decreased 0.67% in 2021 before it grew 2.43% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.4 billion in 2021, then increased by 0.58% to $1.4 billion in 2022, then rose by 1.57% to $1.5 billion in 2023, then rose by 1.27% to $1.5 billion in 2024, then grew by 0.6% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Shares Outstanding (Weighted Average) are $1.5 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025).